United States · Series A startup

Who invested in Delve Bio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $35MJun 2023
Investors
2
See who backed them

The rounds

  1. Jun 2023
    Series A$35M

    Source recorded

Founders and team

From Delve Bio's own website: 4 on the team.

  • Jeff FieldChief Commercial Officer
  • Amy WongSenior Director of Marketing and Business Development
  • Andrew CarrettaDirector of Software Engineering
  • Elly RyuSenior Director of Finance

Everyone who backed them

Google VenturesCorporate VC1round
S32VC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Delve Bio

Who invested in Delve Bio?

Delve Bio's investors include Google Ventures and S32.

How much has Delve Bio raised?

Delve Bio has raised $35M across 1 round since 2023.

When did Delve Bio last raise?

Delve Bio's most recent round was a Series A of $35M in Jun 2023.

What was Delve Bio's biggest round?

Its most recent round, $35M in Jun 2023, is also its largest on record.

Who backed Delve Bio first?

Delve Bio's first round on record, in Jun 2023, was backed by Google Ventures and S32.

What stage is Delve Bio at?

Delve Bio's latest named round is a Series A, in Jun 2023.

Where is Delve Bio based?

Delve Bio is based in the United States.

Companies like Delve Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.